Study S002255

Phase 3 Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01628445
Acronym: SAIL
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: TRIPLE
Status: TERMINATED
Enrollment: 52
Start: 2012-08
Primary completion: 2015-11
Lead sponsor: University of Manitoba
Conditions: Type 2 Diabetes
Interventions: DRUG:liraglutide; DRUG:placebo injection
Results posted: FALSE

Registered primary outcomes

Change in A1c [Baseline to 24 wks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.